Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 14, 2020; 26(22): 3024-3033
Published online Jun 14, 2020. doi: 10.3748/wjg.v26.i22.3024
Published online Jun 14, 2020. doi: 10.3748/wjg.v26.i22.3024
Characteristics | Patients (n = 49) |
Age (yr): Median | 61 |
Sex | |
Men | 33 (67.35) |
Women | 16 (32.65) |
Tumor size | |
≤ 5 cm | 20 (40.8) |
5-7 cm | 17 (34.7) |
> 7 cm | 12 (24.5) |
Site of tumor | |
Upper stomach | 3 (6.1) |
Middle stomach | 31 (63.3) |
Lower stomach | 15 (30.6) |
Type of gastrectomy | |
Total | 34 (69.4) |
Subtotal | 15 (30.6) |
Pathological tumor stage | |
T1 | 2 (4.1) |
T2 | 19 (38.7) |
T3 | 21 (42.9) |
T4 | 7 (14.3) |
Pathological nodal stage | |
N0 | 6 (12.2) |
N1 | 24 (49) |
N2 | 15 (30.6) |
N3 | 4 (8.2) |
AJCC stage | |
IB | 1 (2) |
II | 14 (28.6) |
IIIA | 15 (30.6) |
IIIB | 5 (10.2) |
IV | 14 (28.6) |
Histological type | |
Differentiated | 5 (10.2) |
Undifferentiated | 44 (89.8) |
- Citation: Necula L, Matei L, Dragu D, Pitica I, Neagu AI, Bleotu C, Dima S, Popescu I, Diaconu CC, Chivu-Economescu M. High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients. World J Gastroenterol 2020; 26(22): 3024-3033
- URL: https://www.wjgnet.com/1007-9327/full/v26/i22/3024.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i22.3024